In the early 19th century, when retinoblastoma was first recognised,' early enucleation was recommended in an attempt to achieve a cure, because in the preophthalmoscopic era the tumours had usually reached a large size before they were diagnosed.
Diagnostic and treatment facilities have considerably improved over the years, as has the prognosis both for life and vision. The current trend is towards a more conservative approach, with referral to specific centres that are equipped to deal with these tumours. By careful case selection conservative treatment has achieved excellent results without any adverse effect on the survival of the patients.2-Apart from survival the maximum possible vision after treatment is specially important for children in their upbringing and education. The final vision will be affected by many factors, including the size and site of the tumours, the type of treatment used, the complications of the treatment itself, and the delay in diagnosis. Reese and Ellsworth6 classified retinoblastoma for prognosis, assigning the tumours to 5 groups at the time of diagnosis according to size and site.
The purpose of this paper is to review 116 patients treated for bilateral retinoblastoma and to assess their overall visual prognosis and the factors affecting it. The approach to conservative therapy will be discussed.
Material and methods
The records of 116 patients with bilateral retinoblastoma born between 1960 and 1974 To assess the overall visual prognosis for all the patients a grading system was devised whereby a score was allocated to the final acuity ( Table 1 ). The score for the 2 eyes of each patient was then added, the total giving a figure for the combined acuity of the 2 eyes. The lower the score the worse the combined acuity. For example, a score of 2 means both eyes enucleated while a score of 15 means an acuity of 6/6 in one eye and at least 6/12 in the second (Fig. 1) .
Results
Of the 116 patients with bilateral retinoblastoma 19 (25%) had a positive family history of the disease, while 87 (75%) were sporadic cases. An equal number (4 each) of familial and sporadic cases initially presented with unilateral retinoblastoma but later developed tumours in the second eye. This emphasised the necessity for repeated careful observation of the 2 eyes in any case with unilateral or bilateral retinoblastoma.
SITE OF TUMOUR
The final visual acuity is related to the site of the tumour in Table 2 Twenty-four eyes underwent conservative therapy initially but later required enucleation. In assessing the total number of eyes enucleated it must be noted that a large number of patients had already had one eye enucleated by the referring surgeon. It is possible that some of the eyes could have been saved if treated by specialist methods.
COMPLICATIONS OF TREATMENT
Complications relevant to the final visual outcome occurred in patients undergoing both whole-eye irradiation with the cobalt beam unit and focal irradiation with cobalt plaques. The majority of patients receiving whole-eye irradiation via the anterior field acquired some degree of radiation lens opacities, but not all of these progressed sufficiently to warrant surgical removal. In those who did require surgery the visual outcome was satisfactory on the whole, aphakic correction being achieved with bifocal spectacles. Amblyopia may be a problem in a patient retaining both eyes who develops a unilateral cataract. Table 3 . 258% of eyes achieved on acuity of 6/12 or better after treatment, though 55 2% of the total number of eyes required enucleation (24 eyes underwent conservative treatment initially but later required enucleation).
Fifty-eight patients (50%) achieved a final acuity of 6/12 or better in one eye at the age of eight years, while 2 patients (1.72%) had visual acuities of 6/12 or better in both eyes.
The overall visual prognosis by the grading system devised for this study is shown in Fig. 1 .
Discussion
The prime aim of treatment of retinoblastoma is to preserve life but in addition every attempt is also made to preserve the eye itself and some degree of useful vision. Whether the retinoblastoma is unilateral or bilateral, an approach has evolved in which each eye is assessed on its individual merits when selecting the relevant treatment method. No longer is the one eye in a bilateral case enucleated merely because it is the worse affected, nor the affected eye in a unilateral case, for a unilateral case may later become bilateral, or the so-called 'good'
eye of a bilateral case may develop new tumours at the macula or optic disc.
Early and accurate diagnosis is essential, and this requires an examination under full general anaesthesia with the indirect ophthalmoscope and scleral indentation. Only by this method can small or peripheral tumours be detected early so that they are within the range of treatment by relatively noninvasive methods. The importance of a comprehensive fundal examination is emphasised by Ellsworth, 8 who noted that 75% of patients had tumours situated anterior to the equator.
Infants with a family history of retinoblastoma are examined from the age of 6 weeks, and then at increasing intervals which are modified accordingly if the patient develops a new tumour which requires treatment. The disease in bilateral cases is often asymmetrical, one eye often having smaller tumours when first seen, while a previously unaffected eye may later develop new tumours. Genetic counselling of the parents and the patients themselves, when old enough, is offered.
The selection of a single therapeutic method or a combination of various methods is aimed at dealing with the tumour while minimising. the complications. Conservative methods in regular use include 'wholeeye' irradiation,89 focal irradiation with a cobalt plaque,10 light coagulation,1" and cryotherapy. 12 13 The relative indications for the various treatment methods have been suggested by Bedford7 on the basis of single or multiple tumours, which are graded according to size.
Treatment is time-consuming, and it is therefore important for the family to understand fully what is entailed. At least 50% of patients in this series achieved an acuity of 6/12 or better in at least one eye, so that the child could lead a normal life and attend a normal school. Two patients in fact had visions of 6/12 or better in both eyes.
Because the above forms of therapy are so successful, with a 96% 4-year survival in some units,2 there has been a move away from the automatic excision of either the affected eye in a unilateral case or the worse eye ifi a bilateral case. In the series of Bedford et al. s the only indication for enucleation was involvement of the optic nerve.
Certain complications of the therapeutic methods described above may in themselves adversely affect the visual prognosis, even if the tumour has been satisfactorily dealt with. These include anterior segment damage resulting in comeal or lens opacities, seen after anterior field cobalt beam radiotherapy, or posterior segment vascular changes seen after the application of certain cobalt plaques. A full understanding of the effects and side effects of treatment is needed by ophthalmologist, physicist, and radio-therapist if complications are to be minimised. The indications used in this unit in deciding what form the treatment should take are aimed at reducing the risk of complications while at the same time preserving vision and curing the tumour.
CONCLUSION
With modem therapeutic facilities useful vision may be saved in eyes with retinoblastoma, including those with large tumours which might previously have warranted enucleation. The individual assessment of each eye and the careful selection of the therapeutic method applicable enables the maximal vision to be achieved.
